Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: The COBIS (coronary bifurcation stenting) registry

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2322-2328

  Gwon, Hyeon Cheol ^a,k   Choi, Seung Hyuk ^a,k   Song, Young Bin ^a   Hahn, Joo Yong ^a   Jeong, Myung Ho ^b   Seong, In Whan ^c   Kim, Hyo Soo ^d   Rha, Seung Woon ^e   Yang, Ju Young ^f   Yoon, Jung Han ^g   Tahk, Seung Jea ^h   Seung, Ki Bae ⁱ   Jang, Yangsoo ^j   Park, Seung Jung ^k  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f National Health Insurance Corporation   (South Korea)

^g Wonju Severance Christian Hospital   (South Korea)

^h Ajou University School of Medicine   (South Korea)

ⁱ The Catholic University of Korea   (South Korea)

^j Yonsei University College of Medicine   (South Korea)

^k Asan Medical Center   (South Korea)

more..

Author keywords

Bifurcation; Drug eluting stents; Percutaneous coronary intervention

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BIFURCATION; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78349292977     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0352     Document Type: Article

References (21)

1. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
2. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, et al. Restenosis rates following bifurcation stenting with sirolimuseluting stents for de novo narrowings. Am J Cardiol 2004; 94: 115-118.
3. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: Importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005; 46: 613-620.
4. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006; 114: 1955-1961.
5. Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation 2009; 119: 71-78.
6. Di Mario C, Morici N, Godino C, Goktekin O, Tamburino C, Barbagallo R, et al. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv 2007; 69: 416-424.
7. Collins N, Seidelin PH, Daly P, Ivanov J, Barolet A, Mackie K, et al. Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings. Am J Cardiol 2008; 102: 404-410.
8. Medina A, Suárez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183 (in Spanish).
9. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
10. Ge L, Iakovou I, Cosgrave J, Agostoni P, Airoldi F, Sangiorgi GM, et al. Treatment of bifurcation lesions with two stents: One year angiographic and clinical follow up of crush versus T stenting. Heart 2006; 92: 371-376.
11. Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong AT, Cosgrave J, et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: Predictors of an adverse outcome. J Am Coll Cardiol 2006; 47: 1949-1958.
12. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-Cypher registry. Circulation 2006; 113: 1434-1441.
13. Honda Y. Drug-eluting stents: Insights from invasive imaging technologies. Circ J 2009; 73: 1371-1380.
14. Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009; 73: 1033-1037.
15. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009; 119: 987-995.
16. Kitahara H, Kobayashi Y, Takebayashi H, Fujimoto Y, Nakamura Y, Kuroda N, et al. Re-stenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: Retrospective analysis of 4 Japanese hospitals. Circ J 2009; 73: 867-871.
17. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004; 148: 857-864.
18. Zhang F, Dong L, Ge J. Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: A meta-analysis of randomized trials. Heart 2009; 95: 1676-1681.
19. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 1305-1310.
20. Pan M, Suárez de Lezo J, Medina A, Romero M, Delgado A, Segura J, et al. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007; 153: 15.e1-e7.
21. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005; 46: 633-637.